125 related articles for article (PubMed ID: 31421458)
1. Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms.
Akil H; Rouanet J; Viallard C; Besse S; Auzeloux P; Chezal JM; Miot-Noirault E; Quintana M; Degoul F
Transl Oncol; 2019 Nov; 12(11):1442-1452. PubMed ID: 31421458
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Targeted Radionuclide Therapy Using [
Akil H; Quintana M; Raymond JH; Billoux T; Benboubker V; Besse S; Auzeloux P; Delmas V; Petit V; Larue L; D'Incan M; Degoul F; Rouanet J
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804655
[TBL] [Abstract][Full Text] [Related]
3. [¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models.
Viallard C; Perrot Y; Boudhraa Z; Jouberton E; Miot-Noirault E; Bonnet M; Besse S; Mishellany F; Cayre A; Maigne L; Rbah-Vidal L; D'Incan M; Cachin F; Chezal JM; Degoul F
Eur J Dermatol; 2015; 25(1):29-35. PubMed ID: 25548082
[TBL] [Abstract][Full Text] [Related]
4. Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy.
Rbah-Vidal L; Vidal A; Billaud EM; Besse S; Ranchon-Cole I; Mishellany F; Perrot Y; Maigne L; Moins N; Guerquin-Kern JL; Degoul F; Chezal JM; Auzeloux P; Miot-Noirault E
Neoplasia; 2017 Jan; 19(1):17-27. PubMed ID: 27987437
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of [
Thivat E; Rouanet J; Auzeloux P; Sas N; Jouberton E; Levesque S; Billoux T; Mansard S; Molnar I; Chanchou M; Fois G; Maigne L; Chezal JM; Miot-Noirault E; D'Incan M; Durando X; Cachin F
BMC Cancer; 2022 Apr; 22(1):417. PubMed ID: 35428211
[TBL] [Abstract][Full Text] [Related]
6. Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapy.
Viallard C; Chezal JM; Mishellany F; Ranchon-Cole I; Pereira B; Herbette A; Besse S; Boudhraa Z; Jacquemot N; Cayre A; Miot-Noirault E; Sun JS; Dutreix M; Degoul F
Oncotarget; 2016 Mar; 7(11):12927-36. PubMed ID: 26887045
[TBL] [Abstract][Full Text] [Related]
7. Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent.
Bonnet-Duquennoy M; Papon J; Mishellany F; Labarre P; Guerquin-Kern JL; Wu TD; Gardette M; Maublant J; Penault-Llorca F; Miot-Noirault E; Cayre A; Madelmont JC; Chezal JM; Moins N
Int J Cancer; 2009 Aug; 125(3):708-16. PubMed ID: 19437532
[TBL] [Abstract][Full Text] [Related]
8. Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution.
Bonnet M; Mishellany F; Papon J; Cayre A; Penault-Llorca F; Madelmont JC; Miot-Noirault E; Chezal JM; Moins N
Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-11. PubMed ID: 20444199
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy.
Rouanet J; Benboubker V; Akil H; Hennino A; Auzeloux P; Besse S; Pereira B; Delorme S; Mansard S; D'Incan M; Degoul F; Rouzaire PO
Cancer Immunol Immunother; 2020 Oct; 69(10):2075-2088. PubMed ID: 32447411
[TBL] [Abstract][Full Text] [Related]
10. Radiation dosimetry of [
Jouberton E; Perrot Y; Dirat B; Billoux T; Auzeloux P; Cachin F; Chezal JM; Filaire M; Labarre P; Miot-Noirault E; Millardet C; Valla C; Vidal A; Degoul F; Maigne L
Med Phys; 2018 Nov; 45(11):5251-5262. PubMed ID: 30179267
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.
Degoul F; Borel M; Jacquemot N; Besse S; Communal Y; Mishellany F; Papon J; Penault-Llorca F; Donnarieix D; Doly M; Maigne L; Miot-Noirault E; Cayre A; Cluzel J; Moins N; Chezal JM; Bonnet M
Int J Cancer; 2013 Sep; 133(5):1042-53. PubMed ID: 23404099
[TBL] [Abstract][Full Text] [Related]
12. Phage display library derived peptides that bind to human tumor melanin as potential vehicles for targeted radionuclide therapy of metastatic melanoma.
Howell RC; Revskaya E; Pazo V; Nosanchuk JD; Casadevall A; Dadachova E
Bioconjug Chem; 2007; 18(6):1739-48. PubMed ID: 17907769
[TBL] [Abstract][Full Text] [Related]
13. Adipocytes Promote B16BL6 Melanoma Cell Invasion and the Epithelial-to-Mesenchymal Transition.
Kushiro K; Chu RA; Verma A; Núñez NP
Cancer Microenviron; 2012 Apr; 5(1):73-82. PubMed ID: 21892698
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, radiolabeling and preliminary in vivo evaluation of multimodal radiotracers for PET imaging and targeted radionuclide therapy of pigmented melanoma.
Billaud EM; Maisonial-Besset A; Rbah-Vidal L; Vidal A; Besse S; Béquignat JB; Decombat C; Degoul F; Audin L; Deloye JB; Dollé F; Kuhnast B; Madelmont JC; Tarrit S; Galmier MJ; Borel M; Auzeloux P; Miot-Noirault E; Chezal JM
Eur J Med Chem; 2015 Mar; 92():818-38. PubMed ID: 25637883
[TBL] [Abstract][Full Text] [Related]
15. Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.
Pearlman RL; Montes de Oca MK; Pal HC; Afaq F
Cancer Lett; 2017 Apr; 391():125-140. PubMed ID: 28131904
[TBL] [Abstract][Full Text] [Related]
16. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of quercetin on epithelial to mesenchymal transition in SK-MEL-28 human melanoma cells defined by in vitro analysis on 3D collagen gels.
Patel DH; Sharma N
Onco Targets Ther; 2016; 9():6445-6459. PubMed ID: 27799792
[TBL] [Abstract][Full Text] [Related]
18. Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.
Pal HC; Diamond AC; Strickland LR; Kappes JC; Katiyar SK; Elmets CA; Athar M; Afaq F
Oncotarget; 2016 Jan; 7(2):1227-41. PubMed ID: 26517521
[TBL] [Abstract][Full Text] [Related]
19. Rubus idaeus L Inhibits Invasion Potential of Human A549 Lung Cancer Cells by Suppression Epithelial-to-Mesenchymal Transition and Akt Pathway In Vitro and Reduces Tumor Growth In Vivo.
Chu SC; Hsieh YS; Hsu LS; Chen KS; Chiang CC; Chen PN
Integr Cancer Ther; 2014 May; 13(3):259-73. PubMed ID: 24335666
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
